Closing the gap to achieve HBV elimination by 2030: A global pursuit fueled by regional successes

by Robert J. Wong
Published 2021-11-01

Chronic Kidney Disease in Patients with Chronic Liver Disease: What Is the Price Tag?

by Robert J. Wong, Ramsey C. Cheung
Published 2020-10-01

Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis.

by Robert J Wong, Tram Tran, Harvey Kaufman, Justin Niles, Robert Gish
Published 2019-01-01

Geographic regions with high prevalence of nonalcoholic steatohepatitis-related hepatic fibrosis are also observed to demonstrate high prevalence of metabolic disease risk factors...

by Robert J. Wong, Tram Tran, Harvey Kaufman, Justin Niles, Robert Gish
Published 2020-04-01

Advanced Hepatocellular Carcinoma Tumor Stage at Diagnosis in the 1945‐1965 Birth Cohort Reflects Poor Use of Hepatocellular Carcinoma Screening

by Ann Robinson, Hesam Tavakoli, Benny Liu, Taft Bhuket, Robert J. Wong
Published 2018-09-01

Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score

by Stuart C. Gordon, Nandita Kachru, Emily Parker, Stephanie Korrer, A. Burak Ozbay, Robert J. Wong
Published 2020-07-01

Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States

by Ryan B. Perumpail, Robert J. Wong, Andy Liu, Channa R. Jayasekera, Douglas T. Dieterich, Zobair M. Younossi, Aijaz Ahmed
Published 2016-03-01

Markov modeling in hepatitis B screening and linkage to care

by Martin A. Sehr, Kartik D. Joshi, John M. Fontanesi, Robert J. Wong, Robert R. Bitmead, Robert G. Gish
Published 2017-05-01